TriangleFOR PATIENTS · SOURCE READING
Treatment of Recurrent Childhood Pheochromocytoma and Paraganglioma
Source: Childhood Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: July 21, 2022 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Treatment of recurrent pheochromocytoma and paraganglioma may include the following:
Source links and citations
A clinical trial that checks a sample of the patient's tumor for certain gene changes. The type of targeted therapy that will be given to the patient depends on the type of gene change.
Source links and citations
A clinical trial of a new chemotherapy drug (guadecitabine).
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice